Table 2 Results of in vivo monitoring of the metabolic control

HbA_1c (%)

7.3 ± 1.1 (5.3, 9.2)

6.6 ± 0.8 (5.3, 8.4)

7.0 ± 1.0 (5.3, 9.2)

HbA_1c (mmol/mol)

57 ± 13 (34, 77)

49 ± 9 (34, 68)

52 ± 11 (34, 77)

Period covered with CGM sensors (days)

17.4 ± 4.3 (10.2, 29.6)

16.2 ± 2.2 (10.6, 18.9)

16.8 ± 3.4 (10.2, 29.6)

Time gap between sensor 1 and 2 (days)

26.6 ± 5.9 (18, 43)

29.3 ± 9.2 (19, 50)

28.0 ± 7.7 (18, 50)

Time gap between sensor 2 and 3 (days)

15.7 ± 6.2 (6, 29)

13.8 ± 8.1 (4, 29)

14.7 ± 7.1 (4, 29)

MBG according to WW method (mmol/l)

8.7 ± 1.6 (6.5, 12.4)

7.5 ± 1.0 (6.1, 9.5)

8.1 ± 1.5 (6.1, 12.4)

MBG according to ID method (mmol/l)

8.7 ± 1.6 (6.4, 12.6)

7.5 ± 1.0(6.1, 9.3)

8.1 ± 1.5 (6.1, 12.6)

SD of BG according to WW method (mmol/l)

1.1 ± 0.3 (0.6, 1.4)

1.2 ± 0.7 (0.3, 3.2)

1.2 ± 0.6 (0.3, 3.2)

SD of BG according to ID method (mmol/l)

2.9 ± 0.7 (1.5, 3.9)

2.1 ± 1.0 (1.1, 4.3)

2.5 ± 0.9 (1.1, 4.3)